Ovid Therapeutics Inc (NASDAQ: OVID) kicked off on Monday, down -5.39% from the previous trading day, before settling in for the closing price of $1.67. Over the past 52 weeks, OVID has traded in a range of $0.24-$2.01.
Healthcare Sector giant saw their annual sales surged by 24.72% over the last five years. While this was happening, its average annual earnings per share was recorded -28.29%. With a float of $59.63 million, this company’s outstanding shares have now reached $71.15 million.
Ovid Therapeutics Inc (OVID) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ovid Therapeutics Inc is 16.27%, while institutional ownership is 40.38%. The most recent insider transaction that took place on Feb 26 ’25, was worth 2,956. In this transaction President and COO of this company sold 5,279 shares at a rate of $0.56, taking the stock ownership to the 73,406 shares. Before that another transaction happened on Feb 26 ’25, when Company’s CBFO sold 3,902 for $0.56, making the entire transaction worth $2,185. This insider now owns 67,973 shares in total.
Ovid Therapeutics Inc (OVID) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.13 earnings per share (EPS), higher than consensus estimate (set at -0.17) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -28.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.20% during the next five years compared to 24.72% growth over the previous five years of trading.
Ovid Therapeutics Inc (NASDAQ: OVID) Trading Performance Indicators
Take a look at Ovid Therapeutics Inc’s (OVID) current performance indicators. Last quarter, stock had a quick ratio of 4.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Ovid Therapeutics Inc (OVID)
Analysing the last 5-days average volume posted by the [Ovid Therapeutics Inc, OVID], we can find that recorded value of 1.54 million was better than the volume posted last year of 1.53 million. As of the previous 9 days, the stock’s Stochastic %D was 55.16%.
During the past 100 days, Ovid Therapeutics Inc’s (OVID) raw stochastic average was set at 71.99%, which indicates a significant increase from 60.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1423 in the past 14 days, which was higher than the 0.1252 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5065, while its 200-day Moving Average is $0.7949. Now, the first resistance to watch is $1.6583. This is followed by the second major resistance level at $1.7367. The third major resistance level sits at $1.7833. If the price goes on to break the first support level at $1.5333, it is likely to go to the next support level at $1.4867. Should the price break the second support level, the third support level stands at $1.4083.
Ovid Therapeutics Inc (NASDAQ: OVID) Key Stats
The company with the Market Capitalisation of 112.51 million has total of 71,212K Shares Outstanding. Its annual sales at the moment are 570 K in contrast with the sum of -26,430 K annual income. Company’s last quarter sales were recorded 130 K and last quarter income was -12,160 K.
